Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Tattersfield

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Thorax|April 15, 2010
Is postmenopausal HRT a risk factor for adult-onset asthma?A E Tattersfield
British Journal of Hospital Medicine|November 1, 1992
Continuous subcutaneous beta-agonists in asthmaA E Tattersfield
Thorax|September 2, 2005
When should a long acting {beta} agonist be added to an inhaled corticosteroid?A E Tattersfield
Chest|June 1, 1987
The site of the defect in asthma. Neurohumoral, mediator or smooth muscle?A E Tattersfield
Lancet (London, England)|January 5, 1985
Nebulisers in domiciliary practiceA E Tattersfield
Bulletin Europeen De Physiopathologie Respiratoire|September 1, 1985
Tolerance to beta-agonistsA E Tattersfield
Lancet (London, England)|October 29, 1997
Limitations of current treatmentA E Tattersfield
British Medical Bulletin|January 1, 1992
Asthma. Bronchodilators: new developmentsA E Tattersfield
British Medical Journal|April 29, 1978
Diseases of the respiratory system. Chronic bronchitis and emphysemaA E Tattersfield
Pharmacology & Therapeutics|January 1, 1982
Bronchodilator drugsA E Tattersfield
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Thorax|April 15, 2010
Is postmenopausal HRT a risk factor for adult-onset asthma?A E Tattersfield
British Journal of Hospital Medicine|November 1, 1992
Continuous subcutaneous beta-agonists in asthmaA E Tattersfield
Thorax|September 2, 2005
When should a long acting {beta} agonist be added to an inhaled corticosteroid?A E Tattersfield
Chest|June 1, 1987
The site of the defect in asthma. Neurohumoral, mediator or smooth muscle?A E Tattersfield
Lancet (London, England)|January 5, 1985
Nebulisers in domiciliary practiceA E Tattersfield
Bulletin Europeen De Physiopathologie Respiratoire|September 1, 1985
Tolerance to beta-agonistsA E Tattersfield
Lancet (London, England)|October 29, 1997
Limitations of current treatmentA E Tattersfield
British Medical Bulletin|January 1, 1992
Asthma. Bronchodilators: new developmentsA E Tattersfield
British Medical Journal|April 29, 1978
Diseases of the respiratory system. Chronic bronchitis and emphysemaA E Tattersfield
Pharmacology & Therapeutics|January 1, 1982
Bronchodilator drugsA E Tattersfield
Pageof 18